BNP test for acute coronary syndrome
Part of Heart & circulation clinical trials.
This trial tests if a hormone called BNP (a protein from the heart) can help doctors better understand your sudden heart problem. It may guide treatment or predict recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have acute coronary syndrome (like a heart attack or unstable angina).
- You have not had a heart attack before.
- Your heart's pumping strength (ejection fraction) is 30% or higher.
- You do not have a disease of the heart muscle (cardiomyopathy).
- You do not have serious kidney, liver, cancer, infection, or inflammatory disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about people who come to care with sudden (acute) worsening heart failure symptoms. If your test shows a higher BNP level, your doctors may use your details to better understand and track acute heart failure care.
This study looks at a blood test called NT-proBNP to see if it can help predict how much blockage is in the heart's arteries. It may help doctors better understand heart disease risk.
This trial tests whether checking a blood marker called NT-proBNP at your bedside while in the hospital helps doctors better manage acute heart failure. It could lead to more personalized treatment and a clearer picture of your recovery.
This trial tests a new blood test (NTproBNP) to help diagnose heart failure. It is looking for existing blood samples from people with current or past heart failure symptoms or diagnosis.
This study looks at whether a blood test called BNP can help predict what happens over time in people being evaluated for advanced heart failure treatment. It may help doctors better plan care and follow-up for patients long-term.
This trial is testing a simple blood test (NT-proBNP) to find heart failure early in people who have symptoms but haven't been diagnosed yet. If the test levels are high, it could help doctors start treatment sooner.
Hear when a new Acute Coronary Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.